Sep 30, 2012

Gilead Sciences Q3 2012 Earnings Report

Total Revenue
$2.43B
Previous year: $2.12B
+14.5%
EPS
$0.5
Previous year: $0.48
+4.2%
Gross Profit
$1.83B
Previous year: $1.59B
+15.1%
Cash and Equivalents
$1.55B
Previous year: $909M
+70.5%
Total Assets
$21B
Previous year: $12.6B
+65.9%

Gilead Sciences

Gilead Sciences